ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $2,365,000 | +18.5% | 200,940 | +37.4% | 0.00% | 0.0% |
Q1 2019 | $1,996,000 | +27.0% | 146,221 | -4.7% | 0.00% | 0.0% |
Q4 2018 | $1,572,000 | -45.1% | 153,387 | -10.8% | 0.00% | -33.3% |
Q3 2018 | $2,863,000 | +4.6% | 171,976 | -0.7% | 0.00% | 0.0% |
Q2 2018 | $2,737,000 | +94.9% | 173,235 | +56.7% | 0.00% | +200.0% |
Q1 2018 | $1,404,000 | +19.9% | 110,531 | +8.1% | 0.00% | 0.0% |
Q4 2017 | $1,171,000 | -6.9% | 102,273 | -0.4% | 0.00% | 0.0% |
Q3 2017 | $1,258,000 | +20.6% | 102,731 | +12.8% | 0.00% | 0.0% |
Q2 2017 | $1,043,000 | -28.9% | 91,052 | +29.2% | 0.00% | -50.0% |
Q1 2017 | $1,466,000 | +5.7% | 70,486 | +5.7% | 0.00% | +100.0% |
Q4 2016 | $1,387,000 | -47.4% | 66,671 | -17.2% | 0.00% | -66.7% |
Q3 2016 | $2,638,000 | +36.8% | 80,498 | +4.2% | 0.00% | +50.0% |
Q2 2016 | $1,929,000 | +7.9% | 77,244 | +5.9% | 0.00% | 0.0% |
Q1 2016 | $1,787,000 | -28.6% | 72,970 | -3.7% | 0.00% | -33.3% |
Q4 2015 | $2,502,000 | +10.9% | 75,737 | +9.9% | 0.00% | 0.0% |
Q3 2015 | $2,257,000 | -32.3% | 68,908 | +9.4% | 0.00% | -25.0% |
Q2 2015 | $3,336,000 | +53.4% | 62,983 | -16.4% | 0.00% | +100.0% |
Q1 2015 | $2,174,000 | – | 75,336 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Novo Holdings A/S | 3,201,183 | $40,591,000 | 3.96% |
Cormorant Asset Management, LP | 150,000 | $1,902,000 | 0.39% |
PFM Health Sciences, LP | 1,034,030 | $13,112,000 | 0.30% |
Partner Investment Management, L.P. | 23,660 | $300,000 | 0.11% |
PointState Capital LP | 375,000 | $4,755,000 | 0.09% |
Spark Investment Management LLC | 38,400 | $486,000 | 0.07% |
SECTORAL ASSET MANAGEMENT INC | 89,300 | $1,132,000 | 0.05% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 95,722 | $1,214,000 | 0.05% |
CADIAN CAPITAL MANAGEMENT, LP | 120,000 | $1,522,000 | 0.04% |
Nicholas Investment Partners, LP | 49,341 | $626,000 | 0.04% |